It is a chemicals private limited company based in Srinagar, Jammu & Kashmir, India, established in 2009.
2009 | Srinagar, Jammu & Kashmir, India | Struck OffPharmacon Enterprises Private Limited, a struck off private limited company, was established on 11 June 2009 in Srinagar, Jammu & Kashmir, India. Engaging in medicinal chemical & botanical products within the trade sector, it holds CIN: U24239JK2009PTC003030. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.51 M.
It upholds a compliant status. Its leadership includes Suhail Anwar (Director), Mohammad Ayub Khan (Managing Director). Past directors included Mohammad Saleem, Yasir Sultan Khuroo, Gazanfar Ali Jan. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at Shah Complex Opp. Medicare Diagonostic , Center Karan Nagar, Srinagar, Jammu & Kashmir, 190010.
U24239JK2009PTC003030
003030
11 June 2009
₹1.00 M
₹0.51 M
Roc Jammu
Unlisted
Struck Off
Explore comprehensive insights into Pharmacon Enterprises Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suhail Anwar | Director | 12 Jun 2009 | Current |
| Mohammad Ayub Khan | Managing Director | 11 Jun 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2012 | Past |
| Pramod Abcsdd | Director | 30 Mar 2012 | Past |
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmacon Enterprises Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 46.82% increase. The company also saw a substantial improvement in profitability, with a 67.41% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2017, Pharmacon Enterprises had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pharmacon Enterprises, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pharmacon Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacon Enterprises's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pharmacon Enterprises Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.
Progress on Pharmacon Enterprises Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Jammu. was documented.
Suhail Anwar was appointed as a Director was appointed as a Director on 12 Jun 2009 & has been associated with this company since 16 years 6 months . was recorded as a recent event.
The activity Mohammad Ayub Khan was appointed as a Managing Director was appointed as a Managing Director on 11 Jun 2009 & has been associated with this company since 16 years 6 months . was completed.
Progress on Pharmacon Enterprises Private Limited was registered on 11 Jun 2009 with Roc Jammu & aged 16 years 6 months as per MCA records. was documented.
The CIN of Pharmacon Enterprises Private Limited is U24239JK2009PTC003030.
Pharmacon Enterprises Private Limited is headquartered at Shah Complex Opp. Medicare Diagonostic , Center Karan Nagar, Srinagar, Jammu & Kashmir, 190010.
Pharmacon Enterprises Private Limited was incorporated on 11 June 2009.
The current directors of Pharmacon Enterprises Private Limited are
The primary industry of Pharmacon Enterprises Private Limited is Trade.
Pharmacon Enterprises Private Limited is unlisted.
The authorized capital of Pharmacon Enterprises Private Limited is ₹1.00 M, and the paid-up capital is ₹0.51 M.
The compliance status of Pharmacon Enterprises Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX